SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Jan-24 4:04 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Payment of Exercise | 3,073 | $0.82 | $2,525.08 | (3%) 96.48K to 93.41K | |
03-Jan-24 4:04 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Option Exercise | 7,500 | -- | -- | 8% 88.98K to 96.48K | |
03-Oct-23 4:29 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Payment of Exercise | 2,593 | $0.66 | $1,716.57 | (3%) 91.57K to 88.98K | |
03-Oct-23 4:29 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Option Exercise | 7,500 | -- | -- | 9% 84.07K to 91.57K | |
02-Aug-23 5:58 PM View: | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 74,257 | $1.01 | $74,999.60 | 757% 9.81K to 84.07K | |
05-Jul-23 4:08 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Payment of Exercise | 2,593 | $1.04 | $2,696.72 | (21%) 12.41K to 9.81K | |
05-Jul-23 4:08 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Option Exercise | 7,500 | -- | -- | 153% 4.91K to 12.41K | |
04-Apr-23 8:17 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Payment of Exercise | 2,593 | $1.01 | $2,618.93 | (35%) 7.5K to 4.91K | |
04-Apr-23 8:17 PM View: | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Option Exercise | 7,500 | -- | -- | 100% 0 to 7.5K | |
20-May-21 6:54 PM View: | Metacrine, Inc. (MTCR) | 20-May-21 | Market Purchase | 3,289 | $3.60 | $11,840.40 | 100% 0 to 3.29K | (2%) |